Bioshares have reported yesterday that the market is awaiting news for a commercial deal regarding it's axiron testosterone program and that they had spoken to management and have been informed that the company is progreesing well and is on track.Bioshares remain confident that a significant deal will be reported in the first quarter.
- Forums
- ASX - By Stock
- ACR
- acrux update /bioshares
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.6¢

acrux update /bioshares
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.524M |
Open | High | Low | Value | Volume |
1.5¢ | 1.6¢ | 1.5¢ | $9.887K | 624.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6355 | 0.016 |
4 | 559314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 20000 | 1 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 15.00pm 26/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online